NORTHERN TRUST CORP - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is and the CUSIP is 87164U409. A total of 20 filers reported holding SYNTHETIC BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q3 2023$14,345
-46.1%
26,5990.0%0.00%
Q2 2023$26,599
+6.7%
26,599
-25.5%
0.00%
Q1 2023$24,932
+53.6%
35,6990.0%0.00%
Q4 2022$16,236
-53.6%
35,6990.0%0.00%
Q3 2022$35,00035,6990.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 28,528$19,9240.00%
Renaissance Technologies 34,710$240.00%
ROYAL BANK OF CANADA 7$00.00%
VANGUARD GROUP INC 525,367$366,9160.00%
IFP Advisors, Inc 382$5720.00%
OSAIC HOLDINGS, INC. 47$320.00%
BANK OF AMERICA CORP /DE/ 21$140.00%
WELLS FARGO & COMPANY/MN 110$770.00%
NORTHERN TRUST CORP 35,699$24,9320.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders